Pharmaceutical preformulation is a crucial phase in drug development that focuses on understanding the physical and chemical properties of potential drug candidates before they advance to formulation. This initial stage plays a pivotal role in optimizing drug design, ensuring stability, and predicting how the drug will behave in various dosage forms.
During pharmaceutical preformulation, researchers investigate key parameters such as solubility, stability, and compatibility of the drug with excipients. These studies help in selecting the most suitable form of the drug for further development. Additionally, preformulation studies assess factors like particle size, crystallinity, and polymorphism, influencing the drug's bioavailability and overall efficacy. This proactive approach minimizes the risk of unexpected challenges during later stages of drug development and contributes to the overall success of pharmaceutical formulations.
In essence, pharmaceutical preformulation lays the foundation for informed decision-making, enabling researchers to navigate the complex landscape of drug development with a comprehensive understanding of the physical and chemical attributes of potential therapeutic agents.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand